1. Home
  2. WST vs PHM Comparison

WST vs PHM Comparison

Compare WST & PHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • PHM
  • Stock Information
  • Founded
  • WST 1923
  • PHM 1950
  • Country
  • WST United States
  • PHM United States
  • Employees
  • WST N/A
  • PHM N/A
  • Industry
  • WST Medical/Dental Instruments
  • PHM Homebuilding
  • Sector
  • WST Health Care
  • PHM Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • PHM Nasdaq
  • Market Cap
  • WST 15.6B
  • PHM 21.0B
  • IPO Year
  • WST N/A
  • PHM N/A
  • Fundamental
  • Price
  • WST $227.12
  • PHM $114.76
  • Analyst Decision
  • WST Buy
  • PHM Buy
  • Analyst Count
  • WST 7
  • PHM 15
  • Target Price
  • WST $331.67
  • PHM $132.57
  • AVG Volume (30 Days)
  • WST 646.1K
  • PHM 2.2M
  • Earning Date
  • WST 07-24-2025
  • PHM 07-22-2025
  • Dividend Yield
  • WST 0.37%
  • PHM 0.77%
  • EPS Growth
  • WST N/A
  • PHM 13.61
  • EPS
  • WST 6.37
  • PHM 14.20
  • Revenue
  • WST $2,895,800,000.00
  • PHM $17,890,440,000.00
  • Revenue This Year
  • WST $3.38
  • PHM N/A
  • Revenue Next Year
  • WST $5.85
  • PHM $2.46
  • P/E Ratio
  • WST $35.63
  • PHM $8.05
  • Revenue Growth
  • WST N/A
  • PHM 8.86
  • 52 Week Low
  • WST $187.43
  • PHM $88.07
  • 52 Week High
  • WST $352.33
  • PHM $149.47
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • PHM 67.64
  • Support Level
  • WST $219.60
  • PHM $107.07
  • Resistance Level
  • WST $233.84
  • PHM $116.42
  • Average True Range (ATR)
  • WST 5.29
  • PHM 3.28
  • MACD
  • WST 0.60
  • PHM 0.93
  • Stochastic Oscillator
  • WST 66.82
  • PHM 88.36

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About PHM PulteGroup Inc.

PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.

Share on Social Networks: